Interim report period from January 2018 to June 2018
(WorldNews Sweden)

2018 SECOND QUARTER (Apr-Jun) Operating loss KSEK -3,563 (-2,559) Loss per share SEK -0.04 (-0.12) 2018 FIRST HALF YEAR (Jan-Jun) Operating loss KSEK -6,385 (-5,240) Loss per share SEK -0.07 (-0.25) IMPORTANT EVENTS DURING THE PERIOD On March 22nd , the Company informed that it is close to obtaining CE mark for VagiVital®. This after the Company has received the report of the evaluation of its so called Technical File. The evaluation has been performed by Lloyd`s Register Quality Assurance, Ltd. (LRQA) in England, acting as the Notified Body. The Company submitted the Technical File in January. At the AGM On March 28th, all Board Members were re-elected. On April the 10th, Peptonic Medical...